We hope that you’re enjoying the cooler autumn weather and doing well.
On October 2 we were in Greenville, SC, for the
Us TOO Support Group Meeting and Webcast on radiation therapy
for prostate cancer treatment and the use of hydrogel spacing as rectal protection for prostate cancer radiation patients. The event was hosted by Johnny Payne, Leader of the Us TOO support group in Greenville, SC, in collaboration with Joe Dickey, Leader of the Us TOO support group in Spartanburg, SC. We’d like to thank Johnny and everyone who attended in person and online, physician presenter Dr. Daniel B. Fried and event sponsor Augmenix.
to see the event video
Watch the next Us
TOO Support Group Meeting Webcast on chemotherapy
for treating prostate cancer on Tuesday, October 24, at 6:50 pm Central Time.
to register for the free live webcast
featuring physician presenter Dr. Daniel H. Shevrin and Cliff Whall, Us TOO support group leader in Inverness, IL.
for the event flyer
with the full agenda and all of the meeting details.
If you’re planning to be in the New York metro area on Saturday, November 11, please
join Us TOO for a Community Conversation on Prostate Cancer in Englewood, NJ.
for more information.
investigational clinical study
of Focal MR-Guided Focused Ultrasound Treatment of Localized Intermediate Risk Prostate Lesions is currently enrolling men with Gleason 7 prostate cancer.
to learn more about the PCa003 Study.
PCRI recently launched the
Prostate Cancer Staging Guide
, which focuses educational content on one of five major prostate cancer categories that correlates to a survivor’s stage.
to check it out.
For a window into the European prostate cancer community,
latest newsletter from Europa Uomo
, a coalition of prostate cancer patient groups with representation in 18 European countries.
NEWS YOU CAN USE ARTICLES:
Please note that the content below lists only the title of the article rather than a direct link to the content.
For access to the full article
- Patients with high risk prostate cancer may benefit 'equally' from two new treatments
- Pfizer and Astellas Announce Positive Top-Line Results from Phase 3 PROSPER Trial of XTANDI enzalutamide in Patients with Non-Metastatic...
- New Prostate Cancer Data Have Been Reported by Researchers at Third Military Medical University (Metformin reverses prostate cancer resistance to...
- Reports from Lenox Hill Hospital Advance Knowledge in Prostate Cancer (Heterogeneity of Outcomes in D'Amico Intermediate-Risk Prostate Cancer...
- 10-year Data Shows CyberKnife® System Provides Excellent Long-term Control of Low-Risk Prostate Cancer
- New Prostate Cancer Study Findings Have Been Reported by E. Roggero and Colleagues (The outcome of prostate cancer patients treated with curative...
- Findings from University of Palermo Yields New Data on Prostate Cancer (Treatment with abiraterone in metastatic castration-resistant prostate cancer...
- Recent Findings in Prostate Cancer Described by Researchers from University of Michigan (Two-Stage Biomarker Protocols for Improving the Precision of...
- Data on Prostate Cancer Discussed by Researchers at Biotechnology Research Center (Correlation of Gankyrin oncoprotein overexpression with...
- New Prostate Cancer Findings from Case Western Reserve University Discussed (Cost-effectiveness of MR Imaging-guided Strategies for Detection of...
- Findings on Prostate Cancer Detailed by P. Moise and Co-Authors (Symptoms and Impacts in Non-Metastatic Castration-Resistant Prostate Cancer:...
- New Findings from J.W.S. Young et al Broadens Understanding of Prostate Cancer (Androgen deprivation therapy and the risk of parkinsonism in men with...
- September is National Prostate Cancer Awareness Month
- Findings on Prostate Cancer Detailed by Researchers at University of Alberta (Gene-Set Reduction for Analysis of Major and Minor Gleason Scores Based...
- Data from Medical University of Silesia Provide New Insights into Prostate Cancer (Targeting Apoptotic Activity Against Prostate Cancer Stem Cells)
Watch for the November issue of the
Hot SHEET newsletter from Us TOO in about two weeks and more of the latest prostate cancer
News You Can Use in about one month.
Take care and let us know how we can help you with prostate cancer educational resources and support services.
All the best,